ClinicalTrials.gg
Sign In

Hyperglycemia clinical trials

The registry lists 800 studies for Hyperglycemia across more than 10 countries. 115 are recruiting or about to start. 310 of them are mainly about Hyperglycemia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its narrower condition Glucose Intolerance too: 1,559 studies, 226 open.

ClinicalTrials.gov finds 1,791 studies for Hyperglycemia. How that becomes 800 here

This page counts the studies the registry files under Hyperglycemia, and those it files under no condition that list Hyperglycemiathemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 1,791Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −752Filed under a narrower condition, counted on its own pageGlucose Intolerance 752
  3. −36List Hyperglycemia as a condition, but the registry did not file them under itMost often written as “Stress Hyperglycemia” (5), “Hyperglycemia Due to Type 2 Diabetes Mellitus” (5), and “Hyperglycemia Stress” (4). The registry filed them under other conditions only, most often Diabetes Mellitus, Type 2 (9) and Diabetes Mellitus (8).
  4. −203Match it another way140 name it in the title, 22 in a keyword, and 41 by a synonym or other text the search reads.
  5. 800The count on this page32 of them list Hyperglycemia in their own words; the registry filed them under no condition.

Get an email when these change. Save the Hyperglycemia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
524
Status unknown
74
Recruiting
72
Terminated
41
Not yet recruiting
34
Withdrawn
23

Phase

Phase 4
89
Phase 3
57
Phase 2
56
Phase 1
45
Early Phase 1
13

Where

United States
316
Canada
46
United Kingdom
33
China
32
Denmark
27
Mexico
26

Who runs them

Emory University (17) · Ohio State University (11) · Sanofi (9) · Johns Hopkins University (8) · University of Leeds (7) · University of British Columbia (7) · Washington University School of Medicine (7) · AstraZeneca (6)

What is being tested here

Drugs under test in Hyperglycemia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Insulin1227
Sitagliptin109
Liraglutide103
Insulin Lispro113
Bitter melon extract101
Gluconic acid101
Evexomostat101
TQF3250101
Semaglutide101
Metformin0418

Drug classes tested here GLP-1 receptor agonists 2 open · DPP-4 inhibitors 1 open · SGLT2 inhibitors 10 · Corticosteroids 4

Coming up

2phase 3 studies under way
42studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 72 Hyperglycemia studies recruiting now, 43 (60%) set no upper age limit and 23 (32%) stop at 75 or younger. 11 (15%) take children under 18. 7 (10%) are for women only and 3 (4%) for men only; 15 (21%) take healthy volunteers.

Recruiting studies that take each age, of 72
AgeWomenMen
104 (6%)5 (7%)
1855 (76%)51 (71%)
3058 (81%)54 (75%)
4058 (81%)54 (75%)
5056 (78%)54 (75%)
6555 (76%)55 (76%)
7547 (65%)47 (65%)
8543 (60%)43 (60%)

Across all 800 studies, recruiting or not: 47% stop at 75 or younger and 33% at 65; 12% take children; 4% are for women only and 3% for men only; 29% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Hyperglycemia studies take

Of 24 phase 4 interventional studies under Hyperglycemia, half reached primary completion within 33 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 115 mo5–26 · 17 studies——
Phase 433 mo11–48 · 24 studies——
Interventional, no phase14 mo7–27 · 225 studies—14 mo9–27 · 208 studies
Observational28 mo15–42 · 65 studies—30 mo15–43 · 63 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Results posted2

Newly registered5

Studies

Recruiting first, then most recently updated. Showing 50 of 800. Browse all 800 → or search them.